Literature DB >> 7445517

Metabolism of o-[methyl-14C]toluidine in the F344 rat.

O S Son, D W Everett, E S Fiala.   

Abstract

1. Following a single dose (400 mg/kg s.c.) of o-[methyl-14C]toluidine to male F344 rats, 56% of the 14C was recovered in the 24 h urine, 2.3% in the faeces and 1% as exhaled 14CO2. After 48 h, 83.9% of the 14C appeared in the urine, 3.3% in the faeces and 1.4% was exhaled. 2. Ether-extractable urinary metabolites were separated by h.p.l.c. and identified as: o-toluidine (5.1% dose); azoxytoluene (0.2%); o-nitrosotoluene (less than or equal to 0.1%); N-acetyl-o-toluidine (0.2%); N-acetyl-o-aminobenzyl alcohol (0.3%); 4-amino-m-cresol (0.6%); N-acetyl-4-amino-m-cresol (0.3%); anthranilic acid (0.3%) and N-acetylanthranilic acid (0.3%). 3. Acid-conjugated urinary metabolites (51% of dose), separated by paper electrophoresis and by Sephadex LH-20 chromatography, were identified as sulphates of 4-amino-m-cresol (27.8% dose), N-acetyl-4-amino-m-cresol (8.5%), and 2-amino-m-cresol (2.1%), and glucuronides of 4-amino-m-cresol (2.6%), N-acetyl-4-amino-m-cresol (2.8%) and N-acetyl-o-aminobenzyl alcohol. Evidence for a double acid conjugate of 4-amino-m-cresol was also found. 4. These results show that N-acetylation and hydroxylation at the 4 position of o-toluidine are major metabolic pathways in the rat. Minor pathways include hydroxylation at the 6 position, oxidation of the methyl group and oxidation of the amino group. Sulphate conjugates predominate over glucuronides by a ratio of 6:1.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7445517     DOI: 10.3109/00498258009033781

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  8 in total

1.  Hepatic transcriptomic alterations for N,N-dimethyl-p-toluidine (DMPT) and p-toluidine after 5-day exposure in rats.

Authors:  June K Dunnick; Keith R Shockley; Daniel L Morgan; Amy Brix; Gregory S Travlos; Kevin Gerrish; J Michael Sanders; T V Ton; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2016-09-16       Impact factor: 5.153

2.  Biological monitoring for occupational exposures to o-toluidine and aniline.

Authors:  A W Teass; D G DeBord; K K Brown; K L Cheever; L E Stettler; R E Savage; W W Weigel; D Dankovic; E Ward
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

3.  Quantification of systemic o-toluidine after intrathecal administration of hyperbaric prilocaine in humans: a prospective cohort study.

Authors:  Emmanuel Guntz; Andrea Carini; Stephan Koslitz; Thomas Brüning; Panayota Kapessidou; Tobias Weiss
Journal:  Arch Toxicol       Date:  2021-01-21       Impact factor: 5.153

4.  Methemoglobinemia Induced by Prilocaine in a Child With Noonan Syndrome.

Authors:  Saori Takagi; Shinnosuke Ando; Ryoko Kono; Yuka Oono; Hiroshi Nagasaka; Hikaru Kohase
Journal:  Anesth Prog       Date:  2022-09-01

5.  Genotoxicity of 2,6- and 3,5-dimethylaniline in cultured mammalian cells: the role of reactive oxygen species.

Authors:  Ming-Wei Chao; Min Young Kim; Wenjie Ye; Jing Ge; Laura J Trudel; Crystal L Belanger; Paul L Skipper; Bevin P Engelward; Steven R Tannenbaum; Gerald N Wogan
Journal:  Toxicol Sci       Date:  2012-07-24       Impact factor: 4.849

6.  In vivo metabolism of 3,2'-dimethyl-4-aminobiphenyl (DMAB) bearing on its organotropism in the Syrian golden hamster and the F344 rat.

Authors:  M Nussbaum; E S Fiala; B Kulkarni; K El-Bayoumy; J H Weisburger
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

7.  Biological monitoring of o-toluidine in urine pretreated by an enzymatic deconjugation method.

Authors:  Yoko Eitaki; Makiko Nakano; Toshio Kawai; Kazuyuki Omae; Toru Takebayashi
Journal:  J Occup Health       Date:  2019-04-19       Impact factor: 2.708

8.  Transimination of quinone imines: a mechanism for embedding exogenous redox activity into the nucleosome.

Authors:  Wenjie Ye; Uthpala I Seneviratne; Ming-Wei Chao; Kodihalli C Ravindra; Gerald N Wogan; Steven R Tannenbaum; Paul L Skipper
Journal:  Chem Res Toxicol       Date:  2012-12-03       Impact factor: 3.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.